Joachim Stangier
Joachim Stangier publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Hematology, on topics such as Atrial Fibrillation Management and Outcomes, Heparin-Induced Thrombocytopenia and Thrombosis and Venous Thromboembolism Diagnosis and Management.
- World rank
- #162,327 of 7,710,434 ranked researchers
- Rank in Germany
- #8,298 of 364,343
- Works
- 75
- Citations
- 13k
- Citations per work
- 174.3
What does Joachim Stangier research?
Joachim Stangier's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (4%), Neuroscience (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5066.8%
- Medicine5066.8%
- Everything else1925.8%
- Life Sciences67.4%
- 1Cardiology and Cardiovascular Medicine39% of their works
- 2Surgery12% of their works
- 3Hematology8% of their works
- 4Internal Medicine8% of their works
- 5Molecular Biology4% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Heparin-Induced Thrombocytopenia and Thrombosis
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Neurobiology and Insect Physiology Research
- Blood Pressure and Hypertension Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Renin-Angiotensin System Studies
Which keywords describe Joachim Stangier's research?
The keywords of their largest research topics: Anticoagulant Therapy, Atrial Fibrillation, Diagnosis, Antithrombotic Therapy, Risk Factors, Heparin-Induced Thrombocytopenia, Thrombosis and Inflammation.
- Angiotensin
- Drosophila
- Blood Pressure
- Antihypertensive Drugs
- Cardiovascular Disease
- Protease-Activated Receptors
- Venous Thromboembolism
- Inflammation
- Heparin-Induced Thrombocytopenia
- Antithrombotic Therapy
- Atrial Fibrillation
- Anticoagulant Therapy
- Diagnosis
- Risk Factors
- Thrombosis
- Pulmonary Embolism
- Cardiovascular Events
- Thrombin
- Hypertension
- Aspirin
- Clopidogrel
- Neuroscience
- Renin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Anticoagulant Therapy481 topic
- Atrial Fibrillation481 topic
- Diagnosis382 topics
- Antithrombotic Therapy312 topics
- Risk Factors242 topics
- Heparin-Induced Thrombocytopenia211 topic
- Thrombosis211 topic
- Inflammation202 topics
- Pulmonary Embolism171 topic
- Venous Thromboembolism171 topic
- Cardiovascular Events142 topics
- Protease-Activated Receptors141 topic
- Thrombin141 topic
- Cardiovascular Disease132 topics
- Hypertension132 topics
- Antihypertensive Drugs71 topic
- Aspirin71 topic
- Blood Pressure71 topic
- Clopidogrel71 topic
- Drosophila71 topic
- Neuroscience71 topic
- Angiotensin61 topic
- Renin61 topic
Where does Joachim Stangier work?
Joachim Stangier's main affiliation in the publication record is Boehringer Ingelheim (Germany), Germany.
How many publications and citations does Joachim Stangier have?
OpenAlex counts 75 works and 13,071 citations for Joachim Stangier, an h-index of 40, ranking #162,327 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joachim Stangier. Posts are plain text and can be reported.